Dr. Moussa, I have read with great interest the recent press on the results of your phase I trial Nilotinib for Parkinson's Disease. As the husband and caregiver for a PWP (about 20 years), I can't begin to tell you how much hope and expectation this gives us as well as every other member to the "Parkinson's Community". Your research, creativity and intuition are to be applauded. Sir, I urge you to the greatest extent possible, to accelerate and broaden the next phase of trials of your Nilotinib Research. Respectfully, Tony Adler ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn